$MRVL

Wall Street Analysts Are Bullish on Top Technology Picks

Analysts from Bank of America and Roth MKM maintained Buy ratings on Marvell (MRVL) and Research Solutions (RSSS), respectively. MRVL's average price target is $298.38, implying 27.2% upside, while RSSS's is $3.75, suggesting 74.4% upside. Both analysts are rated 5-star by TipRanks.

Original reporting
Published Sep 12, 2026, 5:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 12, 2026, 8:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Wall Street Analysts Are Bullish on Top Technology Picks — source image
Decision brief

The 30-second read

$MRVLBullishLow
01

Why it matters

Analyst upgrades provide a modest signal but lack a concrete catalyst for immediate trading.

02

Market read

Limited relevance; primarily opinion-based price target updates.

03

What to watch

No recent earnings or product news to substantiate the targets.

Relevance 4/10Novelty 2/10Timing: today

Background

The article summarizes recent analyst coverage for two small-cap technology stocks.

Company-level read

Ticker impact

$MRVLBullishMedium confidence
Context

Analyst Vivek Arya maintains a Buy rating with a $298.38 price target, indicating a 27% upside.

Expected impact

modest upside if investors follow the target

Evidence & confidence

Analyst rating and target are new but lack concrete catalyst.

$RSSSBullishMedium confidence
Context

Analyst Richard Baldry maintains a Buy rating with a $3.50 price target, suggesting a 61% upside.

Expected impact

moderate upside if market reacts to the rating

Evidence & confidence

Analyst opinion is fresh but no material event drives the move.

Market effects

Analyst bullishness may lift sentiment in the broader technology sector.

Limited to U.S. markets where the stocks trade.

Minimal global impact.

Counterpoint

Ratings could be overly optimistic without a new catalyst.

Key entities

  • Vivek Arya

    Bank of America Securities

  • Richard Baldry

    Roth MKM

Related articles

$MRVLMedAI 9/10

Marvell Technology to acquire Lumentum Holdings in historic US$115 billion deal

Marvell Technology Inc agreed to acquire Lumentum Holdings Inc in an all-stock deal valued at $115 billion, aiming to strengthen its position in AI and data center infrastructure. The merger, expected to close by mid-2028, will make Marvell shareholders 67% owners of the combined entity. Both companies' shares fell on the announcement, reflecting investor concerns about the deal's risks and regulatory hurdles.

$MRVLMedAI 9/10

Marvell (MRVL) Shares Drop After $115 Billion All-Stock Merger A

Marvell Technology (MRVL) shares fell after announcing an $115B all-stock merger with Lumentum (LITE). The deal aims to combine their strengths in data infrastructure and photonics, with estimated $1B cost synergies. MRVL's stock is trading at $170.63, 34.5% above its intrinsic GF Value™ of $126.82, indicating overvaluation. The company has a GF Score™ of 81/100, reflecting strong growth but high valuation.

$COHRMedAI 8/10

Coherent Soars 6% as Fabrinet’s 51% Revenue Jump Lifts Optics Stocks Ahead of Earnings

Coherent (COHR) shares rose 6% after Fabrinet reported a 51% revenue increase and raised guidance above estimates. Fabrinet's data center revenue grew 78%, aligning with Coherent's guidance. Coherent reports earnings on Nov. 4, with cash flow concerns due to negative free cash flow of $1.0 billion in fiscal 2026. Marvell's $115 billion deal for Lumentum leaves Coherent as a standalone major laser maker.